MCA & Stakeholders Taskforce meet on the National Action Plan against Substandard & Falsified (SF) Medical Products
MCA and Stakeholders National Taskforce Meet on the National Action Plan on Substandard & Falsified Medical ProductsIn September 2024, the Medicines Control Agency (MCA), in collaboration with stakeholders, validated the National Action Plan on Substandard and Falsified (SF) Medical Products as part of its ongoing efforts to combat the circulation of substandard and falsified medical […]